MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Regardless of impaired renal function, negative myoclonus can be induced by gabapetin and pregabalin

    DY. Kwon, MH. Park (Gyenggi-Do, Republic of Korea)

    Objective: This study evaluated pregabalin- or gabapentin-induced negative myoclonus according to renal function. Background: Gabapentin and pregabalin are commonly used to control neuropathic pain and epilepsy.…
  • 2019 International Congress

    Assessment of a Movement Disorders Video Curriculum for Neurology Clerkships

    S. Bette, D. Shpiner, J. Margolesky, C. Luca, H. Moore, C. Singer, Y. Reyes-Iglesias (Miami, FL, USA)

    Objective: To assess the accessibility of, quality of, appropriateness for training level of, and knowledge gained from newly developed movement disorders didactic videos in a…
  • 2019 International Congress

    Urodynamic study to distinguish multiple system atrophy from Parkinson’s disease

    KW. Park, JH. Shin, NR. Choi, SY. Jo, MS. Choo, SJ. Chung (Seoul, Republic of Korea)

    Objective: To evaluate differences in urodynamic findings between multiple system atrophy (MSA) and Parkinson’s disease (PD) and identify the utility of urodynamic parameters for the…
  • 2019 International Congress

    Fatigue in Parkinson’s Disease

    D. Silva, TR. Alcântara-Silva, AL. Alcântara-Silva, S. Suzuki-Godoy (Goiânia, Brazil)

    Objective: To evaluate the profile of fatigue in PD patients between two groups Background: Parkinson's disease (PD) is neurodegenerative, presenting motor and non-motor symptoms. Fatigue…
  • 2019 International Congress

    Effect of Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy on non-motor symptoms in patients with advance Parkinson’s disease

    V. Vuletic (Rijeka, Croatia)

    Objective: Our aim was to see effects of deep brain stimulation (DBS) and continuous infusion of levodopa-carbidopa intestinal gel (LCIG) on nonmotor symptoms in advanced…
  • 2019 International Congress

    Gait patterns may distinguish Parkinsonian patients with and without mild cognitive impairment: a data mining approach

    M. Amboni, C. Ricciardi, C. de Santis, G. Ricciardelli, S. Cuoco, G. Improta, L. Iuppariello, G. Santangelo, M. Cesarelli, P. Barone (Baronissi (salerno), Italy)

    Objective: To differentiate patients with Parkinson’s disease (PD) with and without mild cognitive impairment (MCI) using quantitative gait variables through a data mining approach Background:…
  • 2019 International Congress

    Cardiovascular autonomic function and MCI in Parkinson’s disease

    CE. Cicero, L. Raciti, R. Monastero, G. Mostile, G. Donzuso, G. Sciacca, A. Luca, C. Terravecchia, L. Giuliano, R. Baschi, M. Davì, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To evaluate the association between cardiovascular dysautonomia and Mild Cognitive Impairment (MCI) in Parkinson’s Disease (PD) patients. Background: Dysautonomic dysfunction and cognitive impairment represent…
  • 2019 International Congress

    The comparison of cognitive function between normal and abnormal FDG-PET in non-demented Parkinson’s disease

    SJ. Kim, EJ. Chung (Busan, Republic of Korea)

    Objective: The aim is to compare the cognitive function between normal and abnormal FDG-PET in non-demented Parkinson’s disease (PD). Background: PD with mild cognitive impairment…
  • 2019 International Congress

    Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson’s Disease

    A. Martini, L. Weis, E. Fiorenzato, R. Schifano, V. Cianci, A. Antonini, R. Biundo (Newcastle-­under­-Lyme, United Kingdom)

    Objective: To investigate whether Parkinson’s disease (PD) cognitive states and phenotypes are associated with changes in prevalence and severity of Impulse control disorder (ICD). Background:…
  • 2019 International Congress

    Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

    M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

    Objective: To study the effect of SLC6A3VNTR on PD patients’ cognition longitudinally. Background: Solute carrier family 6 neurotransmitter transporter dopamine member 3gene (SLC6A3) has two common…
  • « Previous Page
  • 1
  • …
  • 130
  • 131
  • 132
  • 133
  • 134
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley